Nanoparticles in the Treatment of Mental Disorders: A New Tool in the Psychiatric Medication

E-ISSN： 1873-4294|15|4|282-286

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.15, Iss.4, 2015-02, pp. : 282-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Noncompliance with Medication for Psychiatric Disorders: Reasons and Remedies

By Breen R.

CNS Drugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 457-471

Adis International

Access to resources Recommend Favorite

EDITORIAL (Thematic Issue: New Targets of Medical Treatment in Psychiatric Disorders)

Current Neuropharmacology, Vol. 13, Iss. 6, 2015-12 ,pp. : 736-738

Bentham Science Publishers

Access to resources Recommend Favorite

Gabapentin may be a "valuable tool" for adjunctive therapy among patients with bipolar disorders who are refractory to treatment or who have comorbid psychiatric disorders

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Time to Abandon the Self-Medication Hypothesis in Patients with Psychiatric Disorders

By Lembke Anna

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 6, 2012-11 ,pp. : 524-529

Informa Healthcare

Access to resources Recommend Favorite

Medication Treatment for Children and Adolescents with Eating Disorders

Child and Adolescent Psychopharmacology News, Vol. 10, Iss. 7, 2005-11 ,pp. : 1-4

Guilford Publications Inc

Access to resources Recommend Favorite